The study may lead to future breakthroughs in combating destructive tropical diseases like dengue fever, Zika virus and yellow fever.
The researchers focused their efforts on a single species of mosquito, Aedes aegypti, a key player in the spread of such diseases in animals and humans around the world.
"Given the widespread global distribution of the Aedes aegypti mosquito, we estimate over 40 per cent of the world's population is at risk from dengue," said Susanta K Behura, assistant research professor at University of Missouri in the US.
Recent research has shown that fragments of transfer RNA (tRFs), small sections of RNA that can regulate gene expression, play a role in development of disease.
This prompted Behura and his colleagues to collect samples from mosquitoes around the world, which then underwent molecular analysis.
In analysing tRF response to a variety of conditions and stimuli - including sex, developmental stage and exposure to the dengue virus - the team found that a specific tRF was expressed differently when exposed to each of these conditions.
They said that this particular tRF is a promising candidate for further study, raising the possibility of a targeted approach to halting the spread of dengue fever.
"We do not have vaccines for all the different viral diseases caused by this mosquito," Behura said.
"Currently, the best way to fight these mosquitoes is to control them, and the rational way to control human infections is to make them incapable of spreading the disease," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
